Referenties
1Candido KD, Kusper TM, Knezevic NN6. New Cancer Pain Treatment Options. Curr Pain Headache Rep. 2017 Feb;21(2):12
2Mercandante S. Intravenous morphine for management of cancer pain. Lancet Oncol. 2010 May;11(5):484-9.
3Burton AW, Rajagopal A, H, Shah HN et al. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004 Sep;5(3):239-47.
4Bhatia G, Lau ME, Koury KM, Gulur P. Intrathecal Drug Delivery (ITDD) systems for cancer pain. F1000Research. 2014;2:96. doi: 10.12688/f1000research.2-96.v4
5Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery (IDDS) system compared with comprehensive medical management (CMM) for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20(19):4040–9.
6World Health Organization. (1996). Cancer pain relief : with a guide to opioid availability, 2nd ed. World Health Organization. https://apps.who.int/iris/handle/10665/37896. Accessed on April 2020.
7Zheng S, He L, Yang X, Li X, Yang Z. Evaluation of intrathecal drug delivery system for intractable pain in advanced malignancies: A prospective cohort study. Medicine 2017;96(11): e6354-e54.
8Sabharwal T, Katsanos K, Buy X, Gangi A. Image-Guided Ablation Therapy of Bone Tumors. Semin Ultrasound CT MRI. 2009;(2):78-90.
9Di Stasio M, Zugaro L. Gravina GL, et al. A feasibility study of percutaneous Radiofrequency Ablation followed by Radiotherapy in the management of painful osteolytic bone metastases. Eur Radiol . 2011 Sep;21(9):2004-10.
10Goetz MP1, Callstrom MR, Charboneau, et al. J Clin Oncol. 20 04;22(2):300-6. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study.